Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AuGC Partners is a California-based hedge fund manager established in 2017 that manages the AuGC BioFund—a value-oriented equity hedge fund focused on investments in public and private life science and biotechnology companies. The firm has participated in significant PIPE financings for biopharma firms such as Cellectar Biosciences. It acts primarily as an investor rather than an operator or developer of therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AuGC Partners.